PatientsVille.com Logo

Methyl Side Effects

PatientsVille

Common Methyl Side Effects


The most commonly reported Methyl side effects (click to view or check a box to report):

Product Substitution Issue (201)
Headache (192)
Nausea (145)
Pyrexia (119)
Vomiting (113)
Anxiety (101)
Dyspnoea (99)
Agitation (97)
Dizziness (90)
Product Quality Issue (88)
Condition Aggravated (87)
Fatigue (85)
Pain (79)
Abnormal Behaviour (76)
Hypertension (74)
Blood Pressure Increased (71)
Feeling Abnormal (70)
Cardiac Arrest (70)
Disturbance In Attention (69)
Insomnia (68)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Methyl Side Effects Reported to FDA



Methyl Side Effect Report#9999600
Product Substitution Issue
This is a report of a 8-year-old male patient (weight: NA) from US, suffering from the following health symptoms/conditions: NA, who was treated with Methylphenidate (dosage: NA, start time: NS), combined with: NA. and developed a serious reaction and side effect(s): Product Substitution Issue after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Methylphenidate treatment in male patients, resulting in Product Substitution Issue side effect.
Methyl Side Effect Report#9999376
Hypotension, Syncope
This report suggests a potential Methylphenidate Hypotension side effect(s) that can have serious consequences. A 88-year-old male patient (weight: NA) from US was diagnosed with the following symptoms/conditions: NA and used Methylphenidate (dosage: NA) starting
Jun 26, 2013. After starting Methylphenidate the patient began experiencing various side effects, including: Hypotension, SyncopeAdditional drugs used concurrently: NA.The patient was hospitalized. Although Methylphenidate demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Hypotension, may still occur.
Methyl Side Effect Report#9999191
Intracardiac Thrombus, Pulmonary Artery Thrombosis
This Intracardiac Thrombus problem was reported by a health professional from TR. A 26-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: angiopathy,thrombocytopenic purpura,menorrhagia. On NS this consumer started treatment with Methylprednisolone (dosage: NA). The following drugs were being taken at the same time:
  • Immunoglobulins (0.4 Gm/kg;qd;iv)
When using Methylprednisolone, the patient experienced the following unwanted symptoms/side effects: Intracardiac Thrombus, Pulmonary Artery ThrombosisAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Intracardiac Thrombus, may become evident only after a product is in use by the general population.
Methyl Side Effect Report#9999164
Off Label Use, Erythema, Sense Of Oppression
This Off Label Use side effect was reported by a health professional from FR. A 56-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Methylprednisolone (drug dosage: NA), which was initiated on
Dec 05, 2013. Concurrently used drugs:
  • Desloratadine
  • Carboplatin
  • Nebivolol
  • Docetaxel
  • Levothyroxine
.After starting to take Methylprednisolone the consumer reported adverse symptoms, such as: Off Label Use, Erythema, Sense Of OppressionThese side effects may potentially be related to Methylprednisolone.
Methyl Side Effect Report#9998923
Respiratory Failure, Meningitis Cryptococcal, Immune Reconstitution Inflammatory Syndrome
This is a report of a 72-year-old male patient (weight: NA) from JP, suffering from the following health symptoms/conditions: acute febrile neutrophilic dermatosis, who was treated with Methylprednisolone (dosage: NA, start time: NS), combined with: NA. and developed a serious reaction and side effect(s): Respiratory Failure, Meningitis Cryptococcal, Immune Reconstitution Inflammatory Syndrome after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Methylprednisolone treatment in male patients, resulting in Respiratory Failure side effect.
Methyl Side Effect Report#9997873
Transient Ischaemic Attack
This report suggests a potential Methylprednisolone Transient Ischaemic Attack side effect(s) that can have serious consequences. A 62-year-old female patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: NA and used Methylprednisolone (dosage: 100 Mg, Cyclic) starting
Feb 19, 2014. After starting Methylprednisolone the patient began experiencing various side effects, including: Transient Ischaemic AttackAdditional drugs used concurrently: NA. Although Methylprednisolone demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Transient Ischaemic Attack, may still occur.
Methyl Side Effect Report#9996195
Puncture Site Haemorrhage
This Puncture Site Haemorrhage problem was reported by a physician from JP. A 21-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Methylprednisolone Sodium Succinate (dosage: 1000 Mg, Daily). The following drugs were being taken at the same time: NA. When using Methylprednisolone Sodium Succinate, the patient experienced the following unwanted symptoms/side effects: Puncture Site HaemorrhageAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Puncture Site Haemorrhage, may become evident only after a product is in use by the general population.
Methyl Side Effect Report#9994711
Haematochezia, Rectal Haemorrhage, Constipation, Flatulence
This Haematochezia side effect was reported by a consumer or non-health professional from US. A 84-year-old male patient (weight:NA) experienced the following symptoms/conditions: constipation.The patient was prescribed Methylcellulose (drug dosage: NA), which was initiated on NS. Concurrently used drugs:
  • Polyethylene Glycol (Alternate Days / Oral)
.After starting to take Methylcellulose the consumer reported adverse symptoms, such as: Haematochezia, Rectal Haemorrhage, Constipation, FlatulenceThese side effects may potentially be related to Methylcellulose.
Methyl Side Effect Report#9991541
Sepsis, Multi-organ Failure, Acute Respiratory Distress Syndrome, Pneumonia Viral, Rash Vesicular
This is a report of a female patient (weight: NA) from US, suffering from the following health symptoms/conditions: respiratory distress,acute respiratory distress syndrome, who was treated with Methylprednisolone Sodium Succinate (dosage: 3.5 Mg Every 12 Hours For 3 D, start time: NS), combined with: NA. and developed a serious reaction and side effect(s): Sepsis, Multi-organ Failure, Acute Respiratory Distress Syndrome, Pneumonia Viral, Rash Vesicular after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Methylprednisolone Sodium Succinate treatment in female patients, resulting in Sepsis side effect. The patient was hospitalized.
Methyl Side Effect Report#9987816
Treatment Failure
This report suggests a potential Methylprednisolone Sodium Succinate Treatment Failure side effect(s) that can have serious consequences. A 42-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: asthenia,sensory disturbance and used Methylprednisolone Sodium Succinate (dosage: Unk) starting NS. After starting Methylprednisolone Sodium Succinate the patient began experiencing various side effects, including: Treatment FailureAdditional drugs used concurrently: NA. Although Methylprednisolone Sodium Succinate demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Treatment Failure, may still occur.
Methyl Side Effect Report#9981458
Product Substitution Issue, Product Substitution Issue
This Product Substitution Issue problem was reported by a consumer or non-health professional from US. A 12-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: attention deficit/hyperactivity disorder. On
Jun 17, 2013 this consumer started treatment with Methylphenidate Hcl (dosage: 1 Pill Once Daily Taken By Mouth). The following drugs were being taken at the same time: NA. When using Methylphenidate Hcl, the patient experienced the following unwanted symptoms/side effects: Product Substitution Issue, Product Substitution IssueAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Product Substitution Issue, may become evident only after a product is in use by the general population.
Methyl Side Effect Report#9969843
Loeffler^s Syndrome, Strongyloidiasis
This Loeffler^s Syndrome side effect was reported by a health professional from TR. A 82-year-old male patient (weight:NA) experienced the following symptoms/conditions: pemphigoid.The patient was prescribed Methylprednisolone (drug dosage: NA), which was initiated on NS. Concurrently used drugs: NA..After starting to take Methylprednisolone the consumer reported adverse symptoms, such as: Loeffler^s Syndrome, StrongyloidiasisThese side effects may potentially be related to Methylprednisolone. The patient was hospitalized.
Methyl Side Effect Report#9961585
Substance-induced Psychotic Disorder, Incorrect Dose Administered
This is a report of a 17-year-old male patient (weight: NA) from US, suffering from the following health symptoms/conditions: attention deficit/hyperactivity disorder, who was treated with Methylphenidate Hcl (dosage: 20 Mg Per Day In The Morning, start time: NS), combined with: NA. and developed a serious reaction and side effect(s): Substance-induced Psychotic Disorder, Incorrect Dose Administered after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Methylphenidate Hcl treatment in male patients, resulting in Substance-induced Psychotic Disorder side effect.
Methyl Side Effect Report#9960246
Treatment Failure, Product Substitution Issue
This report suggests a potential Methylphenidate Er Treatment Failure side effect(s) that can have serious consequences. A 12-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: attention deficit/hyperactivity disorder and used Methylphenidate Er (dosage: 1 Tablet) starting
Jan 27, 2014. After starting Methylphenidate Er the patient began experiencing various side effects, including: Treatment Failure, Product Substitution IssueAdditional drugs used concurrently: NA. Although Methylphenidate Er demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Treatment Failure, may still occur.
Methyl Side Effect Report#9958716
Thrombocytopenia Neonatal, Premature Baby
This Thrombocytopenia Neonatal problem was reported by a health professional from IN. A male patient (weight: NA) was diagnosed with the following symptoms/conditions: immune thrombocytopenic purpura. On NS this consumer started treatment with Methylprednisolone (dosage: 100 Mg, Transplacental Exposure, Transplacental). The following drugs were being taken at the same time: NA. When using Methylprednisolone, the patient experienced the following unwanted symptoms/side effects: Thrombocytopenia Neonatal, Premature BabyAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Thrombocytopenia Neonatal, may become evident only after a product is in use by the general population.
Methyl Side Effect Report#9940601
Nocardiosis
This Nocardiosis side effect was reported by a physician from JP. A 42-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Methylprednisolone (drug dosage: 500 Mg, Daily), which was initiated on NS. Concurrently used drugs: NA..After starting to take Methylprednisolone the consumer reported adverse symptoms, such as: NocardiosisThese side effects may potentially be related to Methylprednisolone.
Methyl Side Effect Report#9936192
Hepatic Necrosis
This is a report of a 56-year-old male patient (weight: NA) from FR, suffering from the following health symptoms/conditions: central nervous system lymphoma, who was treated with Methylprednisolone (dosage: NA, start time: NS), combined with:
  • Methotrexate
  • Leucovorin Calcium
and developed a serious reaction and side effect(s): Hepatic Necrosis after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Methylprednisolone treatment in male patients, resulting in Hepatic Necrosis side effect.
Methyl Side Effect Report#9935323
Aspergillus Infection
This report suggests a potential Methylprednisolone Aspergillus Infection side effect(s) that can have serious consequences. A 34-year-old male patient (weight: NA) from DE was diagnosed with the following symptoms/conditions: immunosuppression and used Methylprednisolone (dosage: 500 Mg For 3 Days) starting NS. After starting Methylprednisolone the patient began experiencing various side effects, including: Aspergillus InfectionAdditional drugs used concurrently:
  • Cyclophosphamide (0.5 G Twice Within Two Months)
Although Methylprednisolone demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Aspergillus Infection, may still occur.
Methyl Side Effect Report#9935319
Iris Neovascularisation, Retinal Neovascularisation
This Iris Neovascularisation problem was reported by a physician from GR. A 32-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: retinal vasculitis. On NS this consumer started treatment with Methylprednisolone (dosage: 500 Mg/24h). The following drugs were being taken at the same time:
  • Acyclovir (15 Mg/kg/24h)
  • Acyclovir (Unk)
  • Ganciclovir (5 Mg/kg/24h)
  • Ganciclovir (Unk)
When using Methylprednisolone, the patient experienced the following unwanted symptoms/side effects: Iris Neovascularisation, Retinal NeovascularisationThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Iris Neovascularisation, may become evident only after a product is in use by the general population.
Methyl Side Effect Report#9929214
Visual Impairment, Vision Blurred, Retinal Oedema
This Visual Impairment side effect was reported by a consumer or non-health professional from US. A 61-year-old female patient (weight:NA) experienced the following symptoms/conditions: back pain,muscle spasms.The patient was prescribed Methylprednisolone (drug dosage: NA), which was initiated on
Jan 06, 2014. Concurrently used drugs: NA..After starting to take Methylprednisolone the consumer reported adverse symptoms, such as: Visual Impairment, Vision Blurred, Retinal OedemaThese side effects may potentially be related to Methylprednisolone.
Methyl Side Effect Report#9929045
Maternal Exposure During Pregnancy, Gestational Diabetes, Premature Rupture Of Membranes, Procedural Haemorrhage, Diabetes Mellitus, Premature Delivery
This is a report of a 23-year-old female patient (weight: NA) from IN, suffering from the following health symptoms/conditions: immune thrombocytopenic purpura, who was treated with Methylprednisolone Sodium Succinate (dosage: 100 Mg, Initiated Pre-op Then Tapered, Intravenous?(not Otherwise Specified)?, start time: NS), combined with: NA. and developed a serious reaction and side effect(s): Maternal Exposure During Pregnancy, Gestational Diabetes, Premature Rupture Of Membranes, Procedural Haemorrhage, Diabetes Mellitus, Premature Delivery after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Methylprednisolone Sodium Succinate treatment in female patients, resulting in Maternal Exposure During Pregnancy side effect. The patient was hospitalized.
Methyl Side Effect Report#9928665
Hallucination, Visual, Suspiciousness, Verbigeration, Intentional Overdose
This report suggests a potential Methylphenidate Hydrochloride Usp Hallucination, Visual side effect(s) that can have serious consequences. A 17-year-old male patient (weight: NA) from US was diagnosed with the following symptoms/conditions: attention deficit/hyperactivity disorder and used Methylphenidate Hydrochloride Usp (dosage: 90 Mg, 1x/day:qd) starting NS. After starting Methylphenidate Hydrochloride Usp the patient began experiencing various side effects, including: Hallucination, Visual, Suspiciousness, Verbigeration, Intentional OverdoseAdditional drugs used concurrently: NA. Although Methylphenidate Hydrochloride Usp demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Hallucination, Visual, may still occur.
Methyl Side Effect Report#9925073
Dizziness, Headache, Headache, Anxiety, Insomnia, Heart Rate Increased, Thinking Abnormal, Dysphemia
This Dizziness problem was reported by a consumer or non-health professional from US. A 49-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: attention deficit/hyperactivity disorder. On
Dec 23, 2013 this consumer started treatment with Methylphenidate 36 Mg Er Tab (dosage: Once Daily). The following drugs were being taken at the same time: NA. When using Methylphenidate 36 Mg Er Tab, the patient experienced the following unwanted symptoms/side effects: Dizziness, Headache, Headache, Anxiety, Insomnia, Heart Rate Increased, Thinking Abnormal, DysphemiaAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Dizziness, may become evident only after a product is in use by the general population.
Methyl Side Effect Report#9924841
Convulsion, Cerebrovascular Accident, Thrombosis, Gait Disturbance, Pain, Pruritus, Pruritus, Pruritus, Anger
This Convulsion side effect was reported by a consumer or non-health professional from US. A 74-year-old female patient (weight:NA) experienced the following symptoms/conditions: arthralgia,chondropathy,convulsion prophylaxis.The patient was prescribed Methylprednisone (drug dosage: NA), which was initiated on
Dec 25, 2013. Concurrently used drugs: NA..After starting to take Methylprednisone the consumer reported adverse symptoms, such as: Convulsion, Cerebrovascular Accident, Thrombosis, Gait Disturbance, Pain, Pruritus, Pruritus, Pruritus, AngerThese side effects may potentially be related to Methylprednisone. The patient was hospitalized and became disabled.
Methyl Side Effect Report#9921955
Product Substitution Issue, Impulsive Behaviour, Conduct Disorder
This is a report of a 11-year-old male patient (weight: NA) from US, suffering from the following health symptoms/conditions: attention deficit/hyperactivity disorder, who was treated with Methylphenidate Er (dosage: NA, start time: 201312), combined with: NA. and developed a serious reaction and side effect(s): Product Substitution Issue, Impulsive Behaviour, Conduct Disorder after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Methylphenidate Er treatment in male patients, resulting in Product Substitution Issue side effect.


1 of 162 


The appearance of Methyl on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.

What are common Methyl Side Effects for Women?

Women Side EffectsReports
Headache 117
Nausea 98
Product Substitution Issue 81
Pyrexia 62
Vomiting 62
Dyspnoea 59
Agitation 53
Fatigue 53
Product Quality Issue 51
Blood Pressure Increased 48

What are common Methyl Side Effects for Men?

Men Side EffectsReports
Product Substitution Issue 117
Headache 73
Anxiety 56
Pyrexia 56
Condition Aggravated 51
Abnormal Behaviour 50
Vomiting 49
Aggression 47
Cardiac Arrest 45
Agitation 44

Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Methyl reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
    FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

    Discuss Methyl Side Effects

    Did You Have a Methyl Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Methyl for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Methyl Safety Alerts, Active Ingredients, Usage Information

    NDC0093-2931
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameMethyldopa
    NameMethyldopa
    Dosage FormTABLET, FILM COATED
    RouteORAL
    On market since20090223
    LabelerTeva Pharmaceuticals USA Inc
    Active Ingredient(s)METHYLDOPA
    Strength(s)250
    Unit(s)mg/1
    Pharma ClassAdrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]

    More About Methyl

    Side Effects reported to FDA: 4039

    Methyl safety alerts: 2014 2013 2011 2006 2005

    Reported deaths: 264

    Reported hospitalizations: 599

    Methylene Blue: Drug Safety Communication - Serious CNS Reactions Possible When Given to Patients Taking Certain Psychiatric Medications

    [UPDATED 10/21/2011] FDA updated healthcare professionals and the public on the potential drug interaction between methylene blue and serotonergic psychiatric medications. Most cases from the FDA's Adverse Event Reporting System (AERS) of serotonin syndrome in patients given serotonergic psychiatric medications and methylene blue occurred in the context of parathyroid surgery, which involved the intravenous administration of methylene blue as a visualizing agent. Methylene blue doses ranged from 1 mg/kg to 8 mg/kg.

    Because methylene blue is not an FDA-approved drug at this time, and limited data exist regarding its use in various settings, it is not known whether there is a risk of serotonin syndrome in patients taking serotonergic psychiatric medications who are given methylene blue by other routes (e.g., orally or by local tissue injection) or at intravenous doses lower than 1 mg/kg.

    In addition, not all serotonergic psychiatric drugs have an equal capacity to cause serotonin syndrome with methylene blue. The cases of serotonin syndrome with methylene blue occurred in patients taking specific serotonergic psychiatric drugs, namely a selective serotonin reuptake inhibitor (SSRI), a serotonin norepinephrine reuptake inhibitor (SNRI), or clomipramine. It is unclear at this time whether intravenous methylene blue administration in patients receiving other psychiatric drugs with lesser degrees of serotonergic activity poses a comparable risk.

    FDA will update the public when new information is available.

     

    [Posted 07/26/2011]

    AUDIENCE: Emergency Medicine, Critical Care Medicine, Psychiatry

    ISSUE: FDA has received reports of serious central nervous system (CNS) reactions when the drug methylene blue is given to patients taking psychiatric medications that work through the serotonin system of the brain (serotonergic psychiatric medications). A list of the serotonergic psychiatric medications that can interact with methylene blue can be found in the Drug Safety Communication. Safety information about this potential drug interaction and important drug usage recommendations for emergency and non-emergency situations are being added to the drug labels for serotonergic psychiatric medications.

    BACKGROUND: Methylene blue is used to treat methemoglobinemia, vasoplegic syndrome, ifosfamide-induced encephalopathy, and cyanide poisoning. It is also used as a dye in therapeutic and diagnostic applications. Methylene blue is a potent, reversible monoamine oxidase inhibitor (MAOI). Although the exact mechanism of this drug interaction is unknown, methylene blue inhibits the action of monoamine oxidase A — an enzyme responsible for breaking down serotonin in the brain. It is believed that when methylene blue is given to patients taking serotonergic psychiatric medications, high levels of serotonin can build up in the brain, causing toxicity. This is referred to as Serotonin Syndrome — signs and symptoms include mental changes (confusion, hyperactivity, memory problems), muscle twitching, excessive sweating, shivering or shaking, diarrhea, trouble with coordination and/or fever.

    A separate Drug Safety Communication (DSC) is being released today for Zyvox (linezolid) due to similar potential drug interactions with serotonergic psychiatric medications and includes drug usage recommendations.

    RECOMMENDATION: Methylene blue should generally not be given to patients taking serotonergic drugs. However, there are some conditions that may be life-threatening or require urgent treatment with methylene blue such as when it is used in the emergency treatment of methemoglobinemia, ifosfamide-induced encephalopathy, or cyanide poisoning.

    Patients should not stop taking their serotonergic psychiatric medicine without first talking to a healthcare professional. Read the Drug Safety Communication below for other specific recommendations for Healthcare Professionals and for Patients.

    Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

    • Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
    • Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178


    [10/21/2011 - Drug Safety Communication Update - FDA]
    [07/26/2011 – Drug Safety Communication - FDA]

    Latest Methyl clinical trials